Market Access Planning
Analyze the market access pathways and policy environment for comparable products before launch to develop a differentiated market access strategy and accelerate time to market.
Market Access Strategy
In today's increasingly complex market access environment, planning effective access pathways, developing pricing strategies, and identifying regional market opportunities are critical to successful commercialization. Drawing on data covering the National Reimbursement Drug List (NRDL), public procurement and tendering, Huiminbao (commercial health insurance), Patient Assistance Programs (PAPs), and healthcare policies and regulations, the Market Access Strategy solution supports market access planning, pricing analysis, and regional opportunity assessment to accelerate commercialization and market access.
Applications
Applications
NRDL & Tendering Strategy
Leverage historical NRDL and tender pricing data from comparable products to inform negotiation strategies and improve reimbursement success.
Reimbursement Implementation & Penetration
Evaluate regional implementation following reimbursement approval to understand market access performance and refine regional commercialization strategies.
GBI Solutions
Drawing on continuously updated data covering the National Reimbursement Drug List (NRDL), public procurement and tendering, Huiminbao (commercial health insurance), Patient Assistance Programs (PAPs), and healthcare policies and regulations, GBI transforms fragmented market access information into structured, searchable, and actionable intelligence. By reducing the need for manual information gathering, the platform enables market access teams to focus on higher-value strategy development and commercial decision-making.
Comprehensive Data Coverage
GBI brings together comprehensive market access data across key domains, including healthcare policies and regulations, the National Reimbursement Drug List (NRDL), public procurement and tendering, Huiminbao (commercial health insurance), Patient Assistance Programs (PAPs), and the Essential Medicines List (EML). The platform provides market access teams with a single source of trusted market access intelligence, supported by continuously updated data to ensure timely and reliable insights.
Pricing Analysis
Track historical tender winning prices and NRDL price reduction trends over time to help companies pinpoint pricing anchors during NRDL negotiations and tender bidding. Balance market competitiveness with commercial returns by formulating scientific, data-driven pricing strategies.
Innovative Drug Access Pathway Mapping
Analyze market access opportunities for innovative therapies across the National Reimbursement Drug List (NRDL), Huiminbao (commercial health insurance), and Patient Assistance Programs (PAPs). By supporting a diversified market access strategy beyond traditional reimbursement, the platform helps companies accelerate commercialization and sustain post-launch growth.
See the Whole Landscape Shape What's Next in Pharma
GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.
Contact Us